期刊
JOURNAL OF MEDICAL TOXICOLOGY
卷 16, 期 3, 页码 342-345出版社
SPRINGER
DOI: 10.1007/s13181-020-00784-6
关键词
Off-label prescribing; Emergency use authorization; Compassionate use; Expanded access; COVID-19; Coronavirus